Cognitive hearing science

ARCS Foundation Inc. Approves New University Partner, STEM Department

Retrieved on: 
Tuesday, April 5, 2022
University of California, Merced, University, Population, Information science, Mentorship, STEM, Cognition, Public health, Pharmacology, Education, Physics, ARCS, University of California, Research, Informatics, Doctor of Philosophy, Program, Publication, Arizona State University, Health informatics, ARCS Foundation, Nursing, Soil, Medicine, Statistics, Speech, Natural environment, Mathematics, Phoenix, CIS, Technology, Biology, Knowledge, Acquisition, ASU, UC Merced Golden Bobcats, Cognitive hearing science, UC, Student, Science, Department, Epidemiology, San Joaquin Valley, Cognitive science, Engineering, Water, Tutoring, Pharmaceutical industry

LAGRANGE, Ga., April 5, 2022 /PRNewswire-PRWeb/ -- The University of California Merced is the 50th and latest institution added to ARCS Foundation's list of approved academic partners. UC Merced is known for its graduate program excellence and STEM research achievements.

Key Points: 
  • ARCS Foundation added the University of California Merced to its growing list of approved academic partners, plus the Biomedical Informatics program at Arizona State University.
  • The tenth campus, and newest of the University of California system, UC Merced has proven itself as a leading STEM research university since its founding in 2005.
  • ARCS Foundation Board of Directors also approved the Department of Biomedical Informatics at Arizona State University (ASU).
  • The Department of Biomedical Informatics is the second program at Arizona State University to be approved by ARCS National.

Piedmont University Professor Developing App to Prevent Speech-Language Disorders in Children

Retrieved on: 
Monday, December 13, 2021
Piedmont University, Education, Language, Technology, Cognitive hearing science, Life, Communication studies, Vocabulary, Literacy, Success, Interest, Parent, Transport, Interactivity, Lamar University, ASHA, Department, Student, Disorder, Research, Child, Behavior, Awareness, Medical device, Management, Tutoring, Toy, Speech, Science

The article is the latest in a series of research focused on the use of technology in the prevention of speech-language disorders.

Key Points: 
  • The article is the latest in a series of research focused on the use of technology in the prevention of speech-language disorders.
  • The app had a positive impact on parents' attitudes toward storybook reading and the way they read with their children," Harn said.
  • Harn and her fellow researchers have developed an app called Success with Stories that is at the center of their research.
  • Harn's research spills over into her work at Piedmont University, where students are learning that to effectively treat children, they need to understand parents' needs.

Four Members Elected to the ATA Board of Directors to Help Advance Tinnitus Research and Management

Retrieved on: 
Wednesday, October 20, 2021
Veteran, Head, Research, Quality of life, University, Association, College, Benedictine College, CA, Salus University, Communication, MBA, Tinnitus, Hearing loss, Patient, Marketing, University of Bradford, Language, MS, Deafness, Effectiveness, Time, American Tinnitus Association, Brain, ATA, Strategic planning, National, National Institutes of Health, Hartnell College, Doctor of Audiology, University of California, San Francisco, Royal National Institute for Deaf People, Champaign County, Illinois, Computation and Neural Systems, National Institute, Cognitive hearing science, Doctor of Philosophy, Tobacco Products Scientific Advisory Committee, Department, University of Colorado Denver School of Public Affairs, Boston University, Physician, Idaho State University, Dentistry, Management

VIENNA, Va., Oct. 20, 2021 /PRNewswire-PRWeb/ -- The American Tinnitus Association elected four members to its board of directors to further advance its mission to improve evidence-based tinnitus treatments, educate healthcare providers on tinnitus management, and research potential cures.

Key Points: 
  • VIENNA, Va., Oct. 20, 2021 /PRNewswire-PRWeb/ -- The American Tinnitus Association elected four members to its board of directors to further advance its mission to improve evidence-based tinnitus treatments, educate healthcare providers on tinnitus management, and research potential cures.
  • The ATA Board of Directors guides the organization in its efforts to provide guidance on tinnitus management, educate physicians and other healthcare providers on evidence-based tinnitus treatments and management tools, and fund international research initiatives aimed at curing and treating tinnitus.
  • Newly Elected ATA Board Members:
    Sara K. Downs, AuD, is the owner of Hearing Wellness Center and Tinnitus Treatment Center in Duluth, MN.
  • Call the ATA at 1-800-634-8978, if you need general guidance on tinnitus management and finding qualified healthcare providers for care.

Otonomy Announces Publication of Phase 1/2 Trial Results Showing Tinnitus Improvement in Patients Receiving OTO-313

Retrieved on: 
Tuesday, October 12, 2021
Private Securities Litigation Reform Act, Forward-looking statement, Patient, Technology, Pharmacotherapy, Relaxation, SAN, Otorhinolaryngology, Neurotology, COVID-19, GLOBE, Growth, Safety, Sleep, TFI, SEC, Audiology, Ear, U.S. Securities and Exchange Commission, Hearing loss, University, Tinnitus, Cochlea, Security (finance), Cognitive hearing science, Cambridge University Hospitals NHS Foundation Trust, CEO, Therapy, NMDA, Anxiety, Compliance, Risk, Medical device, Pharmaceutical industry

This is also an encouraging moment for clinicians who currently lack any drug therapy to reduce the severity of tinnitus that patients experience.

Key Points: 
  • This is also an encouraging moment for clinicians who currently lack any drug therapy to reduce the severity of tinnitus that patients experience.
  • "Availability of the Phase 1/2 trial results is constructive for our efforts to maintain the favorable pace of patient enrollment in the ongoing Phase 2 trial that is on-track with our anticipated timing for results in mid-2022, said David A. Weber, Ph.D., president and CEO of Otonomy.
  • The exploratory efficacy cohort of the Phase 1/2 trial included 31 evaluable patients with persistent unilateral tinnitus of at least moderate severity based on the TFI.
  • In 2020, we reported positive results from a Phase 1/2 trial of OTO-313 in patients with unilateral tinnitus of at least moderate severity.